Get access to the resources, support, and information you need.
Your Guide to Taking Sandostatin LAR Depot
Sandostatin® (octreotide acetate) comes in 2 different formulations: Sandostatin® (octreotide acetate) Immediate-Release Injection and Sandostatin® LAR Depot (octreotide acetate) for injectable suspension.
- Both formulations contain the same active ingredient, octreotide acetate. The difference between them is how often a patient receives treatment, what type of injection he or she is given, and who gives it (self-injected vs doctor administered)
- If your doctor has prescribed Sandostatin for the first time, you will start treatment with Sandostatin Immediate-Release Injection
- Your doctor will identify if Sandostatin LAR Depot is right for you based on your response after 2 weeks of treatment with Sandostatin Immediate-Release Injection
Here’s What to Expect While Taking Sandostatin Therapy:
Sandostatin LAR Depot:
Administered 2 to 4 times per day during the first 2 weeks of therapy; as an injection under the skin of the thigh, upper arm, or abdomen
Given by self injection
Administered once every 4 weeks as an injection into the muscle tissue of the buttocks
Administered by a trained health care provider
You may be given supplemental Sandostatin Immediate-Release Injection (at the dose you were receiving previously) if you experience symptom flare-ups while on Sandostatin LAR Depot
You are encouraged to report any side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Find simple tips and strategies to help you develop carcinoid-friendly eating habits.
Explore financial support that may help you understand your options and save on your treatment.